Efficacy News and Research

RSS
MU researchers determine efficient method for assessing body composition

MU researchers determine efficient method for assessing body composition

Ocera Therapeutics presents data on prevalence of neurocognitive impairment in cirrhotic patients

Ocera Therapeutics presents data on prevalence of neurocognitive impairment in cirrhotic patients

New drug to stop the growth of prostate cancer tumors investigated

New drug to stop the growth of prostate cancer tumors investigated

Multinational phase II study: GS-9450 can reduce markers of liver damage in patients with NASH

Multinational phase II study: GS-9450 can reduce markers of liver damage in patients with NASH

Akela to terminate lease payment agreement

Akela to terminate lease payment agreement

TruthAboutGardasil.org: Governments need to suspend HPV vaccinations/programs

TruthAboutGardasil.org: Governments need to suspend HPV vaccinations/programs

Pharmacyclics to present on Btk and HDAC programs at AACR 2010

Pharmacyclics to present on Btk and HDAC programs at AACR 2010

Smith & Nephew's ALLEVYN highlighted at SAWC

Smith & Nephew's ALLEVYN highlighted at SAWC

InterMune reports Phase 1b MAD study results of RTV-boosted danoprevir in HCV patients at 45th EASL

InterMune reports Phase 1b MAD study results of RTV-boosted danoprevir in HCV patients at 45th EASL

1440 nm wavelength beneficial in laser-assisted lipolysis for fat-disruption and tissue tightening

1440 nm wavelength beneficial in laser-assisted lipolysis for fat-disruption and tissue tightening

Celsion announces presentation of long-term follow-up data from Phase I ThermoDox dose escalation trial

Celsion announces presentation of long-term follow-up data from Phase I ThermoDox dose escalation trial

Cequent Pharmaceuticals commences toxicology study of CEQ508 tkRNAi-based therapeutic candidate

Cequent Pharmaceuticals commences toxicology study of CEQ508 tkRNAi-based therapeutic candidate

Sunlight Research's Stem Cell Industry Report analyzes U.S. Stem Cell patent landscape

Sunlight Research's Stem Cell Industry Report analyzes U.S. Stem Cell patent landscape

Embryos with two mums to remove the risk of hereditary diseases: new research

Embryos with two mums to remove the risk of hereditary diseases: new research

LOTS results of Myozyme in older children and adults with Pompe disease published

LOTS results of Myozyme in older children and adults with Pompe disease published

Regulus Therapeutics' metabolic disease program data presented at Diabetes Keystone Symposium

Regulus Therapeutics' metabolic disease program data presented at Diabetes Keystone Symposium

Enrollment completed in Impax Pharmaceuticals' APEX-PD trial of IPX066

Enrollment completed in Impax Pharmaceuticals' APEX-PD trial of IPX066

Vertex Pharmaceuticals announces results from Phase 1b clinical trial of VX-222

Vertex Pharmaceuticals announces results from Phase 1b clinical trial of VX-222

Contura submits PMA for Aquamid

Contura submits PMA for Aquamid

Advaxis initiates Phase 2 clinical trial of ADXS11-001 for treatment of CIN

Advaxis initiates Phase 2 clinical trial of ADXS11-001 for treatment of CIN

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.